A method for producing a carbonyl compound represented by formula (1): ##STR00001##
wherein R.sup.1 is hydrogen or an organic group; R.sup.2 is hydrogen or an organic group; and R.sup.3 is hydrogen or an organic group; or two or three of R.sup.1, R.sup.2, and R.sup.3 may be linked to form a ring that may have at least one substituent, the method comprising step A of oxidizing an olefin compound represented by formula (2): ##STR00002##
wherein symbols are as defined above, by an oxidizing agent in the presence of (a) a non-alcohol organic solvent, (b) water, (c) a metal catalyst, and (d) an additive represented by the formula: MXn, wherein M is an element belonging to any one of Group 1, Group 2, Group 13, Group 14, and Group 15 in the periodic table, or NR.sub.4, wherein R is hydrogen or a C.sub.1-10 organic group; X is halogen; and n is a number of 1 to 5.

A method for producing a carbonyl compound represented by formula (1): ##STR00001##
wherein R.sup.1 is hydrogen or an organic group; R.sup.2 is hydrogen or an organic group; and R.sup.3 is hydrogen or an organic group; or two or three of R.sup.1, R.sup.2, and R.sup.3 may be linked to form a ring that may have at least one substituent, the method comprising step A of oxidizing an olefin compound represented by formula (2): ##STR00002##
wherein symbols are as defined above, by an oxidizing agent in the presence of (a) a non-alcohol organic solvent, (b) water, (c) a metal catalyst, and (d) an additive represented by the formula: MXn, wherein M is an element belonging to any one of Group 1, Group 2, Group 13, Group 14, and Group 15 in the periodic table, or NR.sub.4, wherein R is hydrogen or a C.sub.1-10 organic group; X is halogen; and n is a number of 1 to 5.

A method for producing a carbonyl compound represented by formula (1): ##STR00001##
wherein R.sup.1 is hydrogen or an organic group; R.sup.2 is hydrogen or an organic group; and R.sup.3 is hydrogen or an organic group; or two or three of R.sup.1, R.sup.2, and R.sup.3 may be linked to form a ring that may have at least one substituent, the method comprising step A of oxidizing an olefin compound represented by formula (2): ##STR00002##
wherein symbols are as defined above, by an oxidizing agent in the presence of (a) a non-alcohol organic solvent, (b) water, (c) a metal catalyst, and (d) an additive represented by the formula: MXn, wherein M is an element belonging to any one of Group 1, Group 2, Group 13, Group 14, and Group 15 in the periodic table, or NR.sub.4, wherein R is hydrogen or a C.sub.1-10 organic group; X is halogen; and n is a number of 1 to 5.

The present invention provides a method for selectively functionalizing alkanes through a sequential biocatalytic dehydrogenation followed by isomerization-hydrofunctionalization reaction.

The present invention provides a method for selectively functionalizing alkanes through a sequential biocatalytic dehydrogenation followed by isomerization-hydrofunctionalization reaction.

Alkoxylated hydroxycarboxylic acids according to a formula I′ are provided herein, as well as uses thereof and a process for production thereof. ##STR00001##
Compound 2-[2-(2-hydroxyethoxy)ethoxy]propanoic acid being exclude.

Alkoxylated hydroxycarboxylic acids according to a formula I′ are provided herein, as well as uses thereof and a process for production thereof. ##STR00001##
Compound 2-[2-(2-hydroxyethoxy)ethoxy]propanoic acid being exclude.

The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.

The present invention relates to a new chemical synthesis, intermediates and catalysts useful for the preparation of the neprilysin (NEP) inhibitor sacubitril. It further relates to new intermediate compounds and their use for said new chemical synthesis route.

The present invention relates to a novel production method of a novel prostaglandin derivative or a pharmaceutically acceptable salt thereof useful as a medicament, and an intermediate therefor. According to the present invention, a production method of a novel prostaglandin derivative or a pharmaceutically acceptable salt thereof including a conversion step from a compound represented by the following formula 3 to a compound represented by the formula 1 can be provided: ##STR00001##
wherein each symbol is as defined in the DESCRIPTION.